EI
IRWD icon

Ellevest Inc’s Ironwood Pharmaceuticals IRWD Stock Holding History

Ellevest Inc’s Portfolio IRWD Stock Details IRWD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-40
Closed -$496 – 1987
2022
Q4 		$496 Buy
+40
New +$454 ﹤0.01% 1621
2021
Q4 		– Sell
-38
Closed – – 1537
2021
Q3 		$0 Buy
38
+32
+533% +$414 ﹤0.01% 1491
2021
Q2 		$0 Hold
6
– – ﹤0.01% 1335
2021
Q1 		$0 Sell
6
-54
-90% -$570 ﹤0.01% 1298
2020
Q4 		$1K Buy
+60
New +$657 ﹤0.01% 1068
2020
Q2 		– Sell
-93
Closed -$1K – 1221
2020
Q1 		$1K Hold
93
– – ﹤0.01% 904
2019
Q4 		$1K Buy
+93
New +$1.02K ﹤0.01% 794

Other funds holding IRWD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SCM
Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return

Ellevest Inc's IRWD Position: Q1 2023 in Review

Ellevest Inc sold out of Ironwood Pharmaceuticals (IRWD) in Q1 2023, closing a stake of 40 shares — an estimated $496 sold.

Ellevest Inc first reported a position in IRWD in Q4 2019 and held it in 7 quarters. The position peaked at $1K in Q4 2020. 254 funds tracked by Wall St. Rank hold IRWD as of Q1 2023.

  • Ellevest Inc reported no remaining Ironwood Pharmaceuticals position as of Q1 2023 after selling out during the quarter.
  • Ellevest Inc sold 40 Ironwood Pharmaceuticals shares in Q1 2023, an estimated $496.
  • Ellevest Inc first reported a position in Ironwood Pharmaceuticals in Q4 2019 and held it in 7 quarters.
  • Ellevest Inc's Ironwood Pharmaceuticals position peaked at $1K in Q4 2020.
  • 254 funds tracked by Wall St. Rank held Ironwood Pharmaceuticals as of Q1 2023.

Based on Ellevest Inc's 13F filing for Q1 2023, filed 4 May 2023.